Medincell S.A.

France
www.medincell.com
Presenter: Christophe Douat, Corporate Strategies

Medincell S.A. is a private French company committed to the creation and development of long acting parenteral formulations. The corporation, founded in 2002, assists Human and Animal Health companies with MedinGel™, its advanced polymeric drug delivery system. MedinGel™ drastically improves action durations of small molecules, peptides and proteins after one subcutaneous administration; this action duration can be designed between a couple of hours to many months after one injection, depending on the specifications of the drug. As MedinGel allows a perfect compliance to treatments, Medincell works now with 7 Top 10 Animal Health companies on various applications involving companion and food producing animals. Medincell targets an IPO by 2011.